rhDNase {simexaft} | R Documentation |
rhDNase Data Set
Description
This is a dataset reported by Fuchs et al. (1994) for a double-blind randomized multicenter clinical trial designed to evaluate the effect of rhDNase, a recombinant deoxyribonuclease I enzyme, versus placebo on the occurrence of respiratory exacerbations among patients with cystic fibrosis. Data on the occurrence and resolution of all exacerbations were recorded for 645 patients in this trial. For more details about the dataset feature, see Cook and Lawless (2007). Here we only include the first record of the patients that have etype=1.
Usage
data(rhDNase)
Format
A data frame with 641 observations on the following 11 variables.
id
patient identifier
trt
the treatment assignment, trt=1 if patient receive rhDNase and 0 if patent receive placebo
fev
baseline measurement of forced expiratory volume
fev2
baseline measurement of forced expiratory volume
time1
the start of a period indicating when subjects become " at risk" for a transition
time2
if etype=1 then time2 corresponds the onset of an exacerbation (or censoring) and if etype=2 then time2 corresponds to the time of a resolution of an exacerbation (or censoring)
status
status equals 1 if time2 is a transition time and equals 0 if it is a censoring time
etype
the indicator of the nature of the event time recorded in time2
enum
the cumulative number of lines in the data frame for each individual
enum1
the cumulative number of exacerbation-free periods
enum2
a numeric vector
Source
Cook, R. J. and Lawless, J. F. (2007). The Statistical Analysis of Recurrent Events. Springer, New York.